Catalysts for Aucta Pharmaceuticals Inc
14 tracked
Apr 9, 2026
approval
FOSFOMYCIN TROMETHAMINE — FDA approval
FOSFOMYCIN TROMETHAMINE
→
Mar 18, 2026
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Jan 29, 2026
approval
LACOSAMIDE — FDA approval
Aucta Pharmaceuticals Inc
→
Sep 12, 2024
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Oct 12, 2022
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Aug 8, 2022
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Aug 8, 2022
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Aug 8, 2022
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Aug 8, 2022
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Oct 2, 2020
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Apr 17, 2020
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Sep 12, 2019
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
May 30, 2019
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→
Jun 21, 2018
approval
VIGADRONE (VIGABATRIN) — FDA approval
VIGABATRIN
→